Control method and control device for membrane filtration system and membrane filtration system

By controlling the flocculant and pH adjuster injection rates to manage zeta potential, the method prevents fouling and ensures stable membrane filtration performance.

JP2024164972AActive Publication Date: 2024-11-28MEIDENSHA CORP
View PDF 6 Cites 0 Cited by

Patent Information

Application Number
JP2023080734
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Filing Date
2023-05-16
Publication Date
2024-11-28
Estimated Expiration
2043-05-16

AI Technical Summary

Technical Problem

Fouling occurs in filtration membranes due to aggregates adhering to the surface and pores, significantly reducing water permeation performance over time.

Method used

Control the injection rate of a flocculant and/or pH adjuster to maintain the zeta potential of aggregates within a target range, using a control device to adjust the pH value of flocculation-treated water based on the membrane material, thereby reducing aggregate adhesion.

Benefits of technology

Prevents membrane clogging and maintains stable filtration performance by minimizing aggregate adsorption on the filtration membrane.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024164972000001_ABST
    Figure 2024164972000001_ABST
Patent Text Reader

Abstract

To provide a control method for a membrane filtration system that enables membrane filtration in a state where coagulant is less likely to adhere to the membrane and can suppress fouling.SOLUTION: A control method for a membrane filtration system includes a coagulant injection part that injects a coagulant into raw water, and a membrane filter that filters coagulated raw water containing flocs formed by the injection of the coagulant to obtain filtered water. The control method includes a control step for controlling the injection rate of at least one of the coagulant and a pH adjuster so that the zeta potential of the flocs falls within a target range according to the material of the membrane filter, as a pre-treatment for filtration treatment by the membrane filter.SELECTED DRAWING: Figure 1
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to a control method and control device for a filtration membrane system, and a filtration membrane system. [Background technology]

[0002] For example, a coagulation-membrane filtration method in which coagulation treatment is performed in the stage preceding membrane filtration is known as a membrane filtration technology for water purification processes (see, for example, Patent Document 1). In the coagulation-membrane filtration method, a coagulant is injected into raw water, the raw water and the coagulant are mixed, and turbid matter, colloids, dissolved substances, etc. in the raw water react with the coagulant to form coagulants, and the water containing the coagulants is then subjected to membrane filtration to obtain filtered water. [Prior art documents] [Patent documents]

[0003] [Patent Document 1] JP 2014-168729 A Summary of the Invention [Problem to be solved by the invention]

[0004] In the coagulation-membrane filtration method, as operation time passes, the coagulates that flow into the membrane filtration process adhere to the surface and pores of the filtration membrane, and the accumulated coagulates clog the filtration membrane, causing a phenomenon (fouling) in which the water permeability is significantly reduced. From the viewpoint of suppressing fouling and achieving stable membrane filtration, it is preferable to operate the filtration membrane system in a state where coagulates are unlikely to adhere to the filtration membrane.

[0005] The present invention has been made in consideration of the above circumstances, and provides a control method for a filtration membrane system that enables membrane filtration in a state in which aggregates are less likely to adhere to the filtration membrane, and can suppress fouling. [Means for solving the problem]

[0006] One aspect is a control method for a filtration membrane system including a flocculant injection unit that injects a flocculant into raw water, and a filtration membrane that obtains filtrate by filtering flocculated raw water containing flocculants formed by the injection of the flocculant. The control method includes a control step of controlling the injection rate of at least one of the flocculant and the pH adjuster so that the zeta potential of the flocculants falls within a target range according to the material of the filtration membrane as a pretreatment for the filtration by the filtration membrane.

[0007] The above control method may further include a preparation step of acquiring a correspondence relationship between the pH value of the flocculation treatment water and the zeta potential of the flocculant. In the above control step, the pH value of the flocculation treatment water may be monitored, and based on the correspondence relationship, the injection rate of at least one of the flocculant and the pH adjuster may be controlled so that the monitored pH value of the flocculation treatment water falls within a pH value range corresponding to the target range.

[0008] The filtration membrane may be an alumina ceramic membrane. In addition, in the control step, the injection rate of at least one of the flocculant and the pH adjuster may be controlled so that the zeta potential of the flocculant is −7 mV or more. Furthermore, in the above control step, the injection rate of at least one of the flocculant and the pH adjuster may be controlled so that the zeta potential of the flocculant falls within a region on the negative side of the target range.

[0009] In the above control step, a pH adjuster is injected into the raw water at a predetermined ratio, and the injection rate of the flocculant may be controlled so that the zeta potential of the flocculant falls within a target range according to the material of the filtration membrane.

[0010] In the above control step, a flocculant is injected into the raw water at a predetermined ratio, and the injection rate of the pH adjuster may be controlled so that the zeta potential of the flocculants falls within a target range according to the material of the filtration membrane.

[0011] The filtration membrane system according to the above control method may further include a settling tank for performing solid-liquid separation of the flocculated matter upstream of the filtration membrane. The filtration membrane may filter the flocculated water after solid-liquid separation.

[0012] Another aspect is a control device for a filtration membrane system including a flocculant injection unit that injects a flocculant into raw water, and a filtration membrane that filters the flocculated raw water containing flocculants formed by the injection of the flocculant to obtain filtrate. The control device has a control unit that adjusts the injection rate of at least one of the flocculant and the pH adjuster before the filtration process by the filtration membrane so that the zeta potential of the flocculants falls within a target range according to the material of the filtration membrane.

[0013] The control device may further include a memory unit for storing data on a correspondence relationship between the pH value of the flocculation treatment water and the zeta potential of the flocculants. The control unit may acquire the pH value of the flocculation treatment water and control the injection rate of at least one of the flocculant and the pH adjuster based on the correspondence relationship so that the pH value of the flocculation treatment water falls within a pH value range corresponding to a target range.

[0014] Yet another aspect of the filtration membrane system includes a coagulant injection section that injects a coagulant into raw water, a filtration membrane that filters the coagulated raw water containing coagulants formed by the injection of the coagulant to obtain filtered water, and the above-mentioned control device. Effect of the Invention

[0015] According to one embodiment, a method for controlling a filtration membrane system can be provided that enables membrane filtration in a state in which aggregates are less likely to adhere to the filtration membrane, thereby suppressing fouling. [Brief description of the drawings]

[0016] [Figure 1] FIG. 1 is a diagram showing a configuration example of a filtration membrane system according to a first embodiment. [Diagram 2] FIG. 11 is a diagram showing a configuration example of a filtration membrane system according to a second embodiment. [Diagram 3] FIG. 13 is a diagram showing a configuration example of a filtration membrane system according to a third embodiment. [Figure 4] FIG. 13 is a diagram showing a configuration example of a filtration membrane system according to a fourth embodiment. [Diagram 5](a) is a flow chart showing an example of a control method for a filtration membrane system of the first embodiment, (b) is a flow chart showing an example of a control method for a filtration membrane system of the third embodiment, and (c) is a flow chart showing an example of a control method for a filtration membrane system of the fourth embodiment. [Figure 6] 4 is a graph showing the flocculant injection rate, the zeta potential of the flocculants, and the pH of the flocculated treated water in the first embodiment. [Figure 7] FIG. 11 is a graph showing the increase rate of the zeta potential of the flocculants and the transmembrane pressure difference of the filtration membrane when the pH of the flocculation treatment water into which a flocculant has been injected is changed in the first example. [Figure 8] 13 is a graph showing the flocculant injection rate, the zeta potential of the flocculants, and the pH of the flocculated treated water in the second embodiment. [Figure 9] 13 is a graph showing the flocculant injection rate, the zeta potential of the flocculants, and the pH of the flocculated treated water in the third embodiment. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0017] Hereinafter, an embodiment of the present invention will be described with reference to the drawings. In the embodiments, in order to make the description easier to understand, structures and elements other than the main parts of the present invention will be described in a simplified or omitted manner. In addition, in the drawings, the same elements are given the same reference numerals. Note that the shapes, dimensions, etc. of each element shown in the drawings are shown only for illustrative purposes, and do not represent the actual shapes, dimensions, etc.

[0018] (First embodiment) In the first embodiment, in a filtration membrane system combining coagulation treatment and membrane filtration treatment, the coagulant injection rate is controlled in the coagulation treatment prior to the membrane filtration treatment so that the zeta potential of the coagulant generated by coagulant injection falls within a target range according to the material of the filtration membrane. In the first embodiment, the adhesion of the residual coagulant to the filtration membrane surface and pores is reduced by setting the zeta potential of the residual coagulant contained in the raw water (coagulation-treated water) into which coagulant has been injected and which flows into the membrane filtration process to an appropriate range according to the membrane material. This suppresses fouling due to clogging of the filtration membrane, and enables stable membrane filtration.

[0019] 1 is a diagram showing a configuration example of a filtration membrane system according to a first embodiment. The filtration membrane system 1 according to the first embodiment includes a flocculant injection section 2, a retention tank 4, a settling tank 5, a membrane filtration tank 6, and a control device 10.

[0020] Raw water containing turbidity, colloids, and dissolved substances is supplied to the filtration membrane system 1 via a raw water piping 7. The downstream side of the raw water piping 7 is connected to a retention tank 4. As an example, the raw water may be raw water from a water supply, such as river water, groundwater, or lake water, or may be wastewater, such as domestic sewage, rainwater, or industrial wastewater.

[0021] The flocculant injection section 2 is connected to the raw water piping 7 upstream of the retention tank 4, and injects a flocculant into the raw water flowing through the raw water piping 7. Downstream of the flocculant injection section 2, the raw water and the flocculant are mixed, causing the turbidity, colloids, and dissolved substances contained in the raw water to react with the flocculant. This produces flocs in the raw water.

[0022] Examples of the flocculant include ferric chloride, polyferric sulfate, polysilica iron, aluminum sulfate, polyaluminum chloride, high basicity polyaluminum chloride, and mixtures thereof. The flocculant may contain a flocculation aid such as a polymer. In this embodiment, the case where ferric chloride is used as the flocculant will be described.

[0023] The retention tank 4 is a water tank for temporarily retaining the coagulation-treated water containing coagulants. The retention tank 4 is connected to the downstream settling tank 5 via a pipe 7a. The retention tank 4 is also provided with a pH meter 8 for measuring the pH of the coagulation-treated water. The position of the pH meter 8 is not limited to the retention tank 4, and the pH meter 8 may be provided, for example, in the raw water pipe 7 downstream of the coagulant injection section 2.

[0024] The settling tank 5 allows the coagulated treated water flowing in from the retention tank 4 to stand and separates it into solid components and a supernatant liquid. This supernatant liquid is supplied to the downstream membrane filtration tank 6 via piping 7b. The solid components concentrated in the settling tank 5 are transported to an external sludge treatment facility (not shown).

[0025] The membrane filtration tank 6 has a filtration membrane 9 that filters the coagulation-treated water that has been subjected to primary treatment in the settling tank 5. In the membrane filtration tank 6, coagulation remaining in the coagulation-treated water is filtered by the filtration membrane 9, and filtrate from which the coagulation has been separated and removed is generated.

[0026] Examples of the filtration membrane 9 that can be used include ceramic membranes mainly composed of silica, alumina, silicon carbide, cordierite, and mixtures thereof, organic membranes such as PVDF (polyvinylidene fluoride) and PTFE (polytetrafluoroethylene), and hybrid membranes of ceramic membranes and organic membranes. In this embodiment, a case where a ceramic membrane mainly composed of alumina is used as the filtration membrane 9 will be described.

[0027] Here, the ceramic membrane and organic membrane materials used for the filtration membrane 9 each have a positive or negative charge in water. For example, a ceramic membrane mainly composed of alumina has a membrane surface positively charged in near-neutral water or water with a pH of 5 to 8. In addition, in the case of an organic membrane such as PVDF, the membrane surface is usually negatively charged in water.

[0028] For example, when the flocculants contained in the flocculated water are strongly negatively charged in a ceramic membrane mainly composed of alumina, the flocculants are likely to be adsorbed onto the positively charged surface of the membrane, which is likely to cause clogging of the filtration membrane 9. When clogging of the filtration membrane 9 by the flocculants becomes severe, the transmembrane pressure difference increases, causing membrane filtration failure.

[0029] When the membrane material is positively charged in water, if the flocculants contained in the coagulation-treated water are positively charged, the adsorptivity of the flocculants to the membrane surface decreases, slowing down the progress of clogging of the filtration membrane 9. Also, in the above case, even if the flocculants contained in the coagulation-treated water are negatively charged, their adsorptivity to the positively charged membrane surface decreases as the charge decreases. The charge of the aggregate is indicated by the zeta potential. The greater the absolute value of the zeta potential of the aggregate, the greater the charge of the aggregate, and conversely, the smaller the absolute value of the zeta potential of the aggregate, the smaller the charge of the aggregate.

[0030] In the case of organic membranes such as PVDF, the membrane surface is usually negatively charged in water as mentioned above. If the membrane material is negatively charged in water, the aggregates contained in the coagulation treatment water can be negatively charged or the charge on the aggregates can be reduced (i.e., the absolute value of the zeta potential of the aggregates can be reduced), making it difficult for the aggregates to adsorb to the membrane surface.

[0031] Although there are no particular limitations, from the viewpoint of making it difficult for aggregates to be adsorbed onto the membrane surface, in the case of a ceramic membrane whose main component is alumina, it is preferable to adjust the zeta potential of the aggregates to a more positive side than -10 mV (more preferably -7 mV or more).

[0032] In addition, in the case of a ceramic membrane mainly composed of alumina, it is preferable to adjust the zeta potential of the aggregate to fall within the negative region of the target range from the viewpoint of making it difficult for the aggregate to be adsorbed on the membrane surface while suppressing the amount of coagulant injected. As an example, in the case of a ceramic membrane mainly composed of alumina, it is more preferable to adjust the zeta potential of the aggregate to fall within the region of -7 mV or more and near -7 mV (for example, the range of -7 mV or more and -3 mV or less).

[0033] The control device 10 controls the flocculant injection rate of the flocculant injector 2 so that the zeta potential of the flocculants generated in the flocculation process falls within a target range according to the material of the membrane. The control device 10 is, for example, a computer having a CPU (Central Processing Unit) 10a, a memory 10b, and a storage device 10c, and is connected to a pH meter 8 and a flocculant injection unit 2. The CPU 10a and the memory 10b are an example of a control unit, and the memory 10b and the storage device 10c are an example of a storage unit.

[0034] The CPU 10a executes the programs stored in the storage device 10c and controls each element connected to the control device 10. The memory 10b functions as the main memory and work area of ​​the CPU 10a. The storage device 10c is composed of, for example, a hard disk or a solid state drive, and stores the programs and various data required for executing the programs. The control device 10 may be composed of a hardware circuit.

[0035] Here, the correspondence relationship between the zeta potential of the flocculants in the raw water and the pH value differs depending on the type of raw water and the state of the raw water at each time. Therefore, the storage device 10c or memory 10b of this embodiment stores data indicating the correspondence relationship between the zeta potential of the flocculants and the pH value when the flocculant injection rate is changed for the raw water to be treated. Since the above correspondence relationship is known for the raw water to be treated, the pH value when the zeta potential of the flocculants indicates a target range according to the material of the membrane (for example, the zeta potential of the flocculants is on the positive side of -10 mV) can be set as the pH value to be adjusted. The above correspondence data is set before the start of operation of the filtration membrane system 1, but may be updated as appropriate after the start of operation.

[0036] The above-mentioned correspondence data is generated by an operator by preparing multiple samples of coagulation-treated water with different coagulant injection rates and measuring the zeta potential of the coagulation and the pH value of the coagulation-treated water for each sample. In measuring the zeta potential of each sample, for example, the zeta potential of particles of coagulation that are less than a certain size contained in the sample may be measured by electrophoresis, and the zeta potential of the coagulation may be determined by averaging these values. The pH value of each sample may be determined by a general pH measurement method.

[0037] The control device 10 of this embodiment performs the following operation, for example. First, the control device 10 obtains and monitors the current pH value of the flocculation treatment water from the pH meter 8. The current pH value has a correlation with the zeta potential of the flocculants in the flocculation treatment water.

[0038] Then, the control device 10 instructs the flocculant injector 2 to change the flocculant injection rate so that the pH value measured by the pH meter 8 falls within the range of the adjustment target pH value that indicates an appropriate range for the zeta potential of the flocculant. As a result, the flocculant injection rate of the flocculant injector 2 is feedback-controlled according to the pH value of the raw water after the flocculant is injected.

[0039] For example, when the absolute value of the zeta potential of the flocculant estimated from the current pH value is large, the control device 10 increases the flocculant injection rate so as to reduce the pH value and reduce the absolute value of the zeta potential of the flocculant. On the other hand, when the pH value is not within the adjustment target range due to an excessive amount of flocculant injection, the control device 10 reduces the flocculant injection rate under the condition that the pH value is within the adjustment target range. The change amount of the coagulant injection rate may be automatically set by the control device 10 based on a program, or may be set based on an input from an operator.

[0040] FIG. 5(a) is a flow chart showing an example of a control method for the filtration membrane system 1 of the first embodiment. In the preparation step (S1), raw water is collected to prepare multiple samples of coagulation-treated water with different coagulant injection rates, and the zeta potential of the coagulants and the pH value of the coagulation-treated water are measured for each sample. This generates data on the relationship between the zeta potential of the coagulants and the pH value when the coagulant injection rate is changed for the raw water to be treated. The generated data on the relationship is stored in the storage device 10c or memory 10b of the control device 10 and read out by the CPU 10a.

[0041] In the flocculant injection step (S2), the flocculant injection unit 2 injects a flocculant into the raw water in the raw water piping 7 at a set flocculant injection rate. This generates flocculants in the flocculated treated water. The flocculated treated water after the flocculant injection flows into the membrane filtration tank 6 via the retention tank 4 and the settling tank 5, and is filtered by the filtration membrane 9.

[0042] On the other hand, in the pH measurement step (S3), the pH meter 8 measures the pH value of the coagulation treated water after the coagulant is injected. In the injection rate adjustment step (S4), the control device 10 adjusts the coagulant injection rate based on the above-mentioned correspondence data acquired in the preparation step (S1) and the pH value measured in the pH measurement step (S3) so that the zeta potential of the coagulant falls within the range of the adjustment target pH value that indicates an appropriate range. After that, the process returns to S2 and the above-mentioned processing is repeated. Note that the coagulant injection step (S2), the pH measurement step (S3), and the injection rate adjustment step (S4) are examples of control steps.

[0043] As described above, in the flocculant injection section 2 of the first embodiment, the flocculant is injected into the raw water so as to reduce the absolute value of the zeta potential of the flocculant, and the charge of the flocculant is reduced downstream of the flocculant injection section 2. As a result, even if flocculants remaining in the flocculation-treated water flow into the membrane filtration tank 6, clogging of the filtration membrane 9 is unlikely to occur because the flocculants have low adsorption to the surface of the filtration membrane 9.

[0044] In this embodiment, the pH value of the coagulation treatment water after coagulant injection is measured and monitored by a pH meter 8, and the coagulant injection rate is adjusted so that the zeta potential of the coagulant falls within a target pH range that indicates an appropriate range. It is difficult to continuously monitor the zeta potential of the coagulant, but in this embodiment, the coagulant injection rate is controlled using the pH value, making it possible to appropriately control the zeta potential of the coagulant, which is difficult to monitor continuously.

[0045] Second embodiment 2 is a diagram showing a configuration example of a filtration membrane system 1A of the second embodiment. In the following description of the embodiment, elements common to the first embodiment are denoted by the same reference numerals, and duplicated description will be omitted as appropriate.

[0046] The filtration membrane system 1A of the second embodiment is a modified example of the first embodiment, and corresponds to a configuration in which the retention tank 4 and the settling tank 5 are omitted from the filtration membrane system 1 of the first embodiment. In the second embodiment, the downstream side of the raw water piping 7 is connected to the membrane filtration tank 6, and the coagulant injection unit 2 is connected to the raw water piping 7 in the upstream stage of the membrane filtration tank 6. In addition, the membrane filtration tank 6 is provided with a pH meter 8 that measures the pH of the coagulation-treated water. Note that the position of the pH meter 8 is not limited to the membrane filtration tank 6, and the pH meter 8 may be provided, for example, in the raw water piping 7 downstream of the coagulant injection unit 2.

[0047] The control device 10 of the second embodiment, like the first embodiment, instructs the flocculant injector 2 to change the flocculant injection rate so that the pH value measured by the pH meter 8 falls within the range of the adjustment target pH value that indicates an appropriate range for the zeta potential of the flocculant. The configuration of the second embodiment can also provide the same effects as the first embodiment.

[0048] Third embodiment 3 is a diagram showing a configuration example of a filtration membrane system 1B of the third embodiment. The filtration membrane system 1B of the third embodiment is a configuration example in which a pH adjuster and a flocculant are both injected into raw water.

[0049] The filtration membrane system 1B of the third embodiment includes a pH adjuster injection section 3, a flocculant injection section 2, a retention tank 4, a sedimentation tank 5, a membrane filtration tank 6, and a control device 10. The downstream side of the raw water piping 7 of the third embodiment is connected to the retention tank 4. In addition, the raw water piping 7 is connected to the pH adjuster injection section 3 and the flocculant injection section 2. In the third embodiment, the configurations of the flocculant injection section 2, the retention tank 4, the sedimentation tank 5, and the membrane filtration tank 6 are similar to those of the first embodiment.

[0050] The pH adjuster injection section 3 is disposed upstream of the coagulant injection section 2, and injects a pH adjuster at a predetermined ratio into the raw water flowing through the raw water piping 7. Examples of pH adjusters include acids such as hydrochloric acid and sulfuric acid, and alkalis such as caustic soda and lime. However, the types of acids and alkalis of the pH adjuster are not limited to those mentioned above.

[0051] For example, if the membrane material is positively charged in water, the zeta potential of the flocculants produced in the flocculation process can be adjusted to the positive side by adjusting the pH of the raw water to be more acidic with a pH adjuster. Therefore, the adsorption of the flocculants to the membrane surface can be reduced by adjusting the pH of the raw water.

[0052] The configuration and operation of the control device 10 of the third embodiment are similar to those of the first embodiment. However, in the third embodiment, data showing the correspondence relationship between the zeta potential of the flocculant and the pH value when the flocculant injection rate is changed for raw water to be treated is generated by preparing multiple samples of flocculation-treated water in which a pH adjuster is injected at a predetermined ratio and the injection amount of the flocculant is varied, and measuring the zeta potential of the flocculant and the pH value of the flocculation-treated water for each sample.

[0053] FIG. 5(b) is a flowchart showing an example of a control method for the filtration membrane system 1B of the third embodiment. In the preparation step (S11), raw water is collected, and a number of samples of coagulation-treated water are prepared by injecting a pH adjuster at a predetermined ratio and varying the coagulant injection rate, and the zeta potential of the coagulant and the pH value of the coagulation-treated water are measured for each sample. This generates data on the correspondence between the zeta potential of the coagulant and the pH value when the coagulant injection rate is varied for the raw water to be treated. The generated data on the correspondence is stored in the storage device 10c or memory 10b of the control device 10 and read out by the CPU 10a.

[0054] In the pH adjuster injection step (S12), the pH adjuster injection unit 3 injects a pH adjuster into the raw water in the raw water piping 7 at a predetermined ratio. In the flocculant injection step (S13), the flocculant injection unit 2 injects a flocculant into the raw water in the raw water piping 7 at a set flocculant injection rate. This causes the flocculant to react with the turbidity, colloids, and dissolved substances contained in the raw water, producing flocculants in the flocculated treated water. In addition, the flocculated treated water after the injection of the flocculant flows into the membrane filtration tank 6 via the retention tank 4 and the settling tank 5, and is filtered by the filtration membrane 9.

[0055] On the other hand, in the pH measurement step (S14), the pH meter 8 measures the pH value of the coagulation treated water after the coagulant is injected. In the injection rate adjustment step (S15), the control device 10 adjusts the coagulant injection rate based on the above-mentioned correspondence data acquired in the preparation step (S11) and the pH value measured in the pH measurement step (S14) so ​​that the zeta potential of the coagulant falls within the range of the adjustment target pH value that indicates an appropriate range. After that, the process returns to S13 and the above-mentioned processing is repeated. Note that the pH adjuster injection step (S12), the coagulant injection step (S13), the pH measurement step (S14), and the injection rate adjustment step (S15) are examples of control steps.

[0056] As described above, in the third embodiment, a flocculant and a pH adjuster are used in combination, and the flocculant injection section 2 adjusts the flocculant injection rate so that the zeta potential of the flocculant falls within the range of the adjustment target pH value, which indicates an appropriate range. In the third embodiment, the same effects as in the first embodiment can be obtained. Furthermore, in the third embodiment, by using a flocculant and a pH adjuster in combination, there is an advantage that the amount of flocculant used can be reduced compared to when the flocculant is used alone as in the first embodiment.

[0057] In the third embodiment, an example has been described in which the coagulant injection unit 2 injects the coagulant after injecting the pH adjuster at a predetermined ratio, but it is also possible for the pH injection unit 3 to inject the pH adjuster at a predetermined ratio after the coagulant injection unit 2 injects the coagulant.

[0058] (Fourth embodiment) 4 is a diagram showing a configuration example of a filtration membrane system according to a fourth embodiment. The filtration membrane system 1C according to the fourth embodiment is a configuration example in which a pH adjuster and a coagulant are injected into raw water in combination, as in the third embodiment. The fourth embodiment differs from the third embodiment in that the injection rate of the coagulant is fixed at a predetermined ratio, and the injection rate of the pH adjuster is adjusted.

[0059] The filtration membrane system 1C of the fourth embodiment includes a flocculant injection section 2, a pH adjuster injection section 3, a retention tank 4, a sedimentation tank 5, a membrane filtration tank 6, and a control device 10. The downstream side of the raw water piping 7 of the fourth embodiment is connected to the retention tank 4. In addition, the raw water piping 7 is connected to the pH adjuster injection section 3 and the flocculant injection section 2. In the fourth embodiment, the configurations of the retention tank 4, the sedimentation tank 5, and the membrane filtration tank 6 are similar to those of the first embodiment.

[0060] The flocculant injection unit 2 injects a flocculant at a predetermined ratio into raw water flowing through the raw water piping 7. The pH adjuster injection unit 3 is disposed downstream of the flocculant injection unit 2, and injects a pH adjuster into the raw water (flocculated water) flowing through the raw water piping 7. The control device 10 of the fourth embodiment controls the injection rate of the pH adjuster in the pH adjuster injection unit 3 so that the zeta potential of the flocculants generated in the flocculation treatment falls within a target range.

[0061] FIG. 5(c) is a flowchart showing an example of a control method for the filtration membrane system 1C of the fourth embodiment. In the preparation step (S21), raw water is collected, and a number of samples of coagulation-treated water are prepared by injecting a coagulant at a predetermined ratio and varying the injection rate of a pH adjuster, and the zeta potential of the coagulant and the pH value of the coagulation-treated water are measured for each sample. This generates data on the correspondence between the zeta potential of the coagulant and the pH value when the pH adjuster is varied for the raw water to be treated. The generated data on the correspondence is stored in the storage device 10c or memory 10b of the control device 10 and read out by the CPU 10a.

[0062] In the flocculant injection step (S22), the flocculant injection unit 2 injects a flocculant into the raw water in the raw water piping 7 at a predetermined ratio. This produces flocculants in the flocculated treated water. In the pH adjuster injection step (S23), the pH adjuster injection unit 3 injects a pH adjuster into the flocculated treated water in the raw water piping 7 at a set pH adjuster injection rate. The flocculated treated water after the injection of the flocculant and pH adjuster flows into the membrane filtration tank 6 via the retention tank 4 and settling tank 5, and is filtered by the filtration membrane 9.

[0063] On the other hand, in the pH measurement step (S24), the pH meter 8 measures the pH value of the flocculated treated water after the injection of the flocculant and the pH adjuster. In the injection rate adjustment step (S25), the control device 10 adjusts the pH adjuster injection rate based on the above-mentioned correspondence data acquired in the preparation step (S21) and the pH value measured in the pH measurement step (S24) so ​​that the zeta potential of the flocculant falls within the range of the adjustment target pH value, which indicates an appropriate range. After that, the process returns to S23 and the above-mentioned processing is repeated. Note that the flocculant injection step (S22), the pH adjuster injection step (S23), the pH measurement step (S24), and the injection rate adjustment step (S25) are examples of control steps.

[0064] As described above, in the fourth embodiment, the pH value of the flocculation treatment water is adjusted so that the absolute value of the zeta potential of the flocculants is reduced by using a flocculant and a pH adjuster in combination and controlling the injection amount of the pH adjuster. In the fourth embodiment, the same effects as in the third embodiment can be obtained.

[0065] In the fourth embodiment, an example has been described in which the pH adjuster injection unit 3 injects the pH adjuster after injecting the coagulant at a predetermined ratio, but it is also possible for the pH adjuster injection unit 3 to inject the pH adjuster and then the coagulant injection unit 2 to inject the coagulant at a predetermined ratio.

[0066] (First Example) Examples of the present invention will now be described. In the first example, river water was used as raw water and ferric chloride was used as a coagulant. The coagulant injection rate was changed to measure the zeta potential of the coagulants contained in the supernatant water of the coagulated water and the pH of the coagulated water. A zeta potential measuring device using electrophoresis (Malvern, Zetasizer, Nano ZS) was used to measure the zeta potential.

[0067] Fig. 6 is a graph showing the flocculant injection rate, the zeta potential of the flocculants, and the pH of the flocculant-treated water in the flocculant-treated water of Example 1. The horizontal axis of Fig. 6 shows the flocculant injection rate, the vertical axis on the left side of Fig. 6 shows the zeta potential, and the vertical axis on the right side of Fig. 6 shows the pH of the flocculant-treated water. The solid line graph in Fig. 6 shows the change in zeta potential versus the flocculant injection rate, and the dashed line graph in Fig. 6 shows the change in pH of the flocculant-treated water versus the flocculant injection rate.

[0068] Usually, flocculants contained in river water are negatively charged. Even in the case of the first example shown in Figure 6, when the injection rate of the flocculant (ferric chloride) was zero, the zeta potential of the flocculant was -22 mV, and the flocculant was negatively charged. In the first example, as the injection rate of ferric chloride increased, the zeta potential of the flocculant rose to near zero, and finally the zeta potential turned positive. In other words, Figure 6 shows that as the injection rate of ferric chloride increased, the absolute value of the zeta potential became smaller, and the amount of charge on the surface of the flocculant became smaller.

[0069] In addition, the pH of the river water used as raw water in the first embodiment was 8.0, but the pH decreased with an increase in the injection rate of ferric chloride, and when the injection rate was 60 mg / L, it decreased to pH 5.0. In the first embodiment, when the injection rate of ferric chloride was 24 mg / L, the pH was 6.5, and the zeta potential of the flocculated material under the conditions was -7 mg / L (Example 1 in FIG. 7, which will be described later). When the injection rate of ferric chloride was 28 mg / L, the pH was 6.2, and the zeta potential of the flocculated material under the conditions was -5 mV (Example 2 in FIG. 7, which will be described later). Furthermore, when the injection rate of ferric chloride was 34 mg / L, the pH was 6.0, and the zeta potential of the flocculated material under the conditions was -3 mV (Example 3 in FIG. 7, which will be described later). From the graph in FIG. 6, it can be seen that the coagulant injection rate can be controlled so that the zeta potential of the flocculated material becomes a predetermined value by monitoring the pH.

[0070] In addition, in the first embodiment, the rate of increase in the transmembrane pressure during membrane filtration was measured to evaluate the stability of membrane filtration in the membrane filtration process. A membrane module incorporating multiple ceramic flat membranes was applied to the membrane filtration process of the first embodiment. The membrane module was structured to collect filtrate from each ceramic flat membrane in a water collection pipe. The membrane module was immersed in a membrane separation tank, a filtration pump was connected to the water collection pipe through piping, and membrane filtrate was obtained by suction with the filtration pump. The transmembrane pressure was calculated from the value of a pressure gauge installed in the filtration piping, and the rate of increase in the transmembrane pressure was obtained from the change over time.

[0071] Fig. 7 is a diagram showing the zeta potential of the flocculants and the rate of increase in the transmembrane pressure of the filtration membrane when the pH of the flocculation treatment water into which a flocculant has been injected is changed in Example 1. In Fig. 7, when the pH setting value is set to 6.8 to 7.4 (Comparative Examples 1 to 3 in Fig. 7), the zeta potential of the flocculants is in the range of -15 to -10 mV. In the cases of Comparative Examples 1 to 3, the rate of increase in the transmembrane pressure is 20 to 30 kPa / d, which indicates that membrane clogging progresses at a fast rate.

[0072] 7, when the pH setting value is set to 6.0 to 6.5 (Examples 1 to 3 in FIG. 7), the injection rate of ferric chloride is 24 to 34 mg / L, the zeta potential of the aggregates is in the range of -3 to -7 mV, and the rate of increase in the transmembrane pressure is 1.2 to 2.0 kPa / d. In the cases of Examples 1 to 3, the transmembrane pressure rate can be reduced to less than one tenth of that in Comparative Examples 1 to 3.

[0073] As described above, according to the first embodiment, by injecting a coagulant and controlling the pH of the coagulation treatment water so that the zeta potential of the coagulant falls within a predetermined range, it is possible to significantly suppress membrane blockage and achieve stable membrane filtration.

[0074] (Second Example) The second example is an example in which pH adjustment by a pH adjuster and injection of a coagulant are used in combination, similar to the third embodiment. In the second example, river water was used as raw water, sulfuric acid was used as the pH adjuster, and ferric chloride was used as the coagulant. The coagulant injection rate was changed to measure the zeta potential of the coagulants contained in the supernatant water of the coagulated treated water and the pH of the coagulated treated water. The pH of the original river water was 8.0, but in the second example, the pH of the raw water was adjusted to 7.0 before the coagulant was injected by pre-injecting sulfuric acid.

[0075] 8 is a graph showing the coagulant injection rate, the zeta potential of the coagulant, and the pH of the coagulated water in Example 2. FIG. 8 can be read in the same way as FIG.

[0076] When sulfuric acid was pre-injected as in Example 2, it was found that the zeta potential of the flocculate could be adjusted to -7 to -3 mV with an injection rate of ferric chloride of 14 to 23 mg / L. The rate of increase in the transmembrane pressure difference in the above range was 1.2 to 2.0 kPa / d, and stable membrane filtration was achieved as in Examples 1 to 3 in Figure 7 above.

[0077] Comparing the second embodiment with the first embodiment described above, the ferric chloride injection rate in the first embodiment, in which no pH adjustment was performed in addition to coagulant injection, was 24-34 mg / L, whereas the ferric chloride injection rate in the second embodiment was 14-23 mg / L. In other words, it can be seen that by combining coagulant injection and pH adjustment with a pH adjuster as in the second embodiment, it is possible to achieve stable membrane filtration while keeping the coagulant injection rate low.

[0078] (Third Example) In the third example, river water was used as the raw water and aluminum sulfate was used instead of ferric chloride as the coagulant. The coagulant injection rate was changed and the zeta potential of the coagulants contained in the supernatant water of the coagulation-treated water and the pH of the coagulation-treated water were measured.

[0079] 9 is a graph showing the coagulant injection rate, the zeta potential of the coagulant, and the pH of the coagulated water in Example 3. FIG. 9 can be read in the same way as FIG.

[0080] In the first embodiment in which ferric chloride was used as the flocculant, the pH was 6.0 to 6.5 when the flocculant injection rate was 24 to 34 mg / L, and the zeta potential of the flocculant under these conditions was -3 to -7 mV. On the other hand, as shown in Fig. 9, in the third embodiment in which aluminum sulfate was used as the flocculant, the pH was 6.0 to 6.5 when the flocculant injection rate was 80 to 120 mg / L, and the zeta potential of the flocculant under these conditions was -3 to -7 mV. The rate of increase in the transmembrane pressure difference in the above range was 1.2 to 2.0 kPa / d, and stable membrane filtration was achieved as in the first to third embodiments in Fig. 7.

[0081] According to the third embodiment, it is understood that even when a flocculant different from that in the first embodiment is used, the same effect as in the first embodiment can be obtained.

[0082] The present invention is not limited to the above-described embodiment, and various improvements and design changes may be made without departing from the spirit of the present invention.

[0083] In the above embodiment, an example has been described in which the control device 10 changes the injection rate of either the flocculant or the pH adjuster. However, the control device 10 may perform control to change both the injection rate of the flocculant and the injection rate of the pH adjuster.

[0084] In addition, the embodiments disclosed herein should be considered to be illustrative and not restrictive in all respects. The scope of the present invention is defined by the claims, not the above description, and is intended to include all modifications within the meaning and scope of the claims. [Explanation of symbols]

[0085] 1, 1A, 1B, 1C... filtration membrane system, 2... flocculant injection section, 3... pH adjuster injection section, 4... retention tank, 5... sedimentation tank, 6... membrane filtration tank, 7... raw water piping, 7a, 7b... piping, 8... pH meter, 9... filtration membrane, 10... control device, 10a... CPU, 10b... memory, 10c... storage device

Claims

1. A control method for a filtration membrane system including a flocculant injection unit that injects a flocculant into raw water, and a filtration membrane that filters flocculated treated water of the raw water containing flocculants formed by the injection of the flocculant to obtain filtrate, As a pretreatment of the filtration process using the filtration membrane, a control step is provided in which an injection rate of at least one of the flocculant and the pH adjuster is controlled so that the zeta potential of the flocculant falls within a target range according to the material of the filtration membrane. Control methods.

2. The method further includes a preparation step of acquiring a correspondence relationship between the pH value of the flocculation treatment water and the zeta potential of the flocculation, In the control step, Monitor the pH value of the coagulation treated water; Based on the correspondence relationship, an injection rate of at least one of the flocculant and the pH adjuster is controlled so that the monitored pH value of the flocculated treated water falls within a pH value range corresponding to the target range. The method for controlling a filtration membrane system according to claim 1 .

3. The filtration membrane is an alumina-based ceramic membrane, In the control step, the injection rate of at least one of the flocculant and the pH adjuster is controlled so that the zeta potential of the flocculant is −7 mV or more. A method for controlling a filtration membrane system according to claim 1 or 2.

4. In the control step, The injection rate of at least one of the flocculant and the pH adjuster is controlled so that the zeta potential of the flocculant falls within the negative region of the target range. The method for controlling a filtration membrane system according to claim 3.

5. In the control step, The pH adjuster is injected into the raw water at a predetermined ratio, The injection rate of the flocculant is controlled so that the zeta potential of the flocculant falls within a target range according to the material of the filtration membrane. A method for controlling a filtration membrane system according to claim 1 or 2.

6. In the control step, The coagulant is injected into the raw water at a predetermined ratio, The injection rate of the pH adjuster is controlled so that the zeta potential of the aggregate falls within a target range according to the material of the filtration membrane. A method for controlling a filtration membrane system according to claim 1 or 2.

7. The filtration membrane system further includes a settling tank for performing solid-liquid separation of the flocculated matter upstream of the filtration membrane, The filtration membrane filters the coagulated water after solid-liquid separation. A method for controlling a filtration membrane system according to claim 1 or 2.

8. A control device for a filtration membrane system including a flocculant injection unit that injects a flocculant into raw water, and a filtration membrane that filters the flocculated water of the raw water containing flocculants formed by the injection of the flocculant to obtain filtrate water, A control device having a control unit that adjusts the injection rate of at least one of the flocculant and the pH adjuster so that the zeta potential of the flocculant falls within a target range corresponding to the material of the filtration membrane, prior to the filtration process by the filtration membrane.

9. The method further includes a memory unit for storing data on a correspondence relationship between a pH value of the flocculation treatment water and a zeta potential of the flocculation, The control unit is The pH value of the coagulation treated water is obtained, Based on the correspondence relationship, an injection rate of at least one of the flocculant and the pH adjuster is controlled so that the pH value of the flocculated water falls within a pH value range corresponding to the target range. The control device according to claim 8.

10. A flocculant injection unit that injects a flocculant into the raw water; A filtration membrane that filters the coagulated raw water containing the coagulants formed by the injection of the coagulant to obtain filtrate; A control device according to claim 8 or claim 9; A filtration membrane system comprising:

Citation Information

Patent Citations

  • Method for removing particulate matter from aqueous suspension

    JP2002136969A

  • Water treating method and its device

    JP2009248028A

  • Method for operating film module

    JP2010227836A

  • Method for evaluating membrane-clogging property of to-be-treated water, method for determining flocculation treatment condition of to-be-treated water, and apparatus for evaluating membrane-clogging property of to-be-treated water

    JP2022006582A

  • Solid-liquid separation method

    WO2013187378A1